Skip to main content

Impact and Control of Valley Fever - A Workshop

Completed

Coccidioidomycosis, or “Valley fever”, is a fungal disease caused by inhalation of Coccidioides spores from the soil. This fungus, generally found in arid environments in the southwestern US and Latin America, can cause severe debilitating, and sometimes fatal, illness in humans and animals. Despite the public health burden of this disease, a lack of research investment has led to limited options for treatment and control. This workshop will convene experts to discuss the epidemiology and public health impact of Valley Fever, as well as opportunities to facilitate development of diagnostics, therapeutics, and vaccines.

Description

A planning committee of the National Academies of Sciences, Engineering, and Medicine will organize a public workshop to review the epidemiology of coccidioidomycosis (Valley Fever), its impact on populations, and currently available diagnostic and treatment options. The workshop will explore prospects for control of the disease through vaccination.
Specifically, the workshop will feature invited presentations and discussions on the following topics:

  • Overview of valley fever in human and animal populations to include current surveillance programs and diagnostic and treatment options;
  • Epidemiology of valley fever in the United States and throughout the Americas;
  • Impact of climate change on persistence and spread of Coccidioides;
  • Risk of disease by occupation, ethnicity, and immunogenetic susceptibility and impact on endemic communities;
  • Economic impact of valley fever;
  • Immunology of valley fever and potential prevention through vaccination;
  • Potential vaccine platforms and current animal models;
  • Strengthening research and research partnerships on overall fungal diseases for therapeutics or vaccine development;
  • Regulatory pathways for a fungal disease vaccine;
  • Vaccine acceptance and communication.

Speakers and discussants will contribute perspectives from academia, local, national and international public health, pharmaceutical industries, and government regulatory institutions. The planning committee will organize the workshop, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.

Collaborators

Committee

Chair

Member

Member

Member

Member

Member

Member

Member

Elizabeth (Liz) Ashby

Staff Officer

Sponsors

California Health Care Foundation

Department of Health and Human Services

Private: For Profit

Private: Non Profit

Staff

Julie Pavlin

Lead

Liz Ashby

Lead

Julie Liao

Claire Biffl

Justin Hammerberg

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.